Is your organization ready to respond to the *next* paclitaxel?

- Tweet0
- 0
- Pin It 0
- 0
- Subscribe to RSS
Subscribe

Subject: Is your organization ready to respond to the next paclitaxel?

In other words - what processes do you have in place to incorporate new information quickly into clinical practice—especially when there's uncertainty around patient safety?

We're still thinking about OhioHealth system's quick response to the paclitaxel controversy last year, which we touched on in our last Quality Matters news brief—and we want to hear your perspective.

Does your organization have robust processes in place to respond quickly to new clinical information?

Join the discussion on Twitter ›

Don't have a Twitter? Send me a quick reply -

I'd love to add your perspective to the conversation.

Kurt Jensen

Communications Director

Accreditation for Cardiovascular Excellence

Association/Foundation Headquarters, PO Box 2007, 23113, Midlothian, United States

You may unsubscribe or change your contact details at any time.

Subscribe

Subject: Is your organization ready to respond to the *next* paclitaxel?

Subject: Is your organization ready to respond to the next paclitaxel?